These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 23613266)
1. Border between aplastic anemia and myelodysplastic syndrome. Yamazaki H; Nakao S Int J Hematol; 2013 May; 97(5):558-63. PubMed ID: 23613266 [TBL] [Abstract][Full Text] [Related]
2. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults. Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075 [TBL] [Abstract][Full Text] [Related]
3. CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS. Cha CH; Park CJ; Chi HS; Seo EJ; Jang S; Cho YU; Lee KH; Lee JH; Lee JH; Im HJ; Seo JJ Ann Lab Med; 2014 Nov; 34(6):426-32. PubMed ID: 25368817 [TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Barrett J; Saunthararajah Y; Molldrem J Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908 [TBL] [Abstract][Full Text] [Related]
5. Aplastic anaemia versus hypocellular myelodysplastic syndrome. Varma N; Varma S; Marwaha N; Garewal G Indian J Cancer; 1995 Sep; 32(3):110-5. PubMed ID: 8772810 [TBL] [Abstract][Full Text] [Related]
6. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia. Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956 [TBL] [Abstract][Full Text] [Related]
8. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor. Kasahara S; Hara T; Itoh H; Ando K; Tsurumi H; Sawada M; Yamada T; Ohnishi H; Moriwaki H Br J Haematol; 2002 Jul; 118(1):181-8. PubMed ID: 12100146 [TBL] [Abstract][Full Text] [Related]
9. [A study of hypoplastic myelodysplastic syndrome]. Sato Y; Mituhashi S; Otani K; Kamoshita M; Hasegawa Y; Ninomiya H; Nagasawa T; Abe T Rinsho Ketsueki; 1993 Nov; 34(11):1431-7. PubMed ID: 8254904 [TBL] [Abstract][Full Text] [Related]
10. A flow cytometric approach to compare stem cell apoptosis in aplastic anemia and hypoplastic myelodysplastic syndrome. Ibrahim M; Khodeary A; Aziz SP; Mahmoud MG; Abdel-Baset AA; Mohamed T; Sayed SA Hematol Oncol Stem Cell Ther; 2024 Jul-Sep 01; 17(3):184-189. PubMed ID: 39412754 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of immune pathophysiology in patients with bone marrow failure. Nakao S Int J Hematol; 2024 Mar; 119(3):231-239. PubMed ID: 36609840 [TBL] [Abstract][Full Text] [Related]
12. Increased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure. Seiki Y; Sasaki Y; Hosokawa K; Saito C; Sugimori N; Yamazaki H; Takami A; Nakao S Haematologica; 2013 Jun; 98(6):901-7. PubMed ID: 23403320 [TBL] [Abstract][Full Text] [Related]
13. Hemogram and bone marrow morphology in children with chronic aplastic anemia and myelodysplastic syndrome. Wen JQ; Feng HL; Wang XQ; Pang JP World J Pediatr; 2008 Feb; 4(1):36-40. PubMed ID: 18402250 [TBL] [Abstract][Full Text] [Related]
14. Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors. Forester CM; Sartain SE; Guo D; Harris MH; Weinberg OK; Fleming MD; London WB; Williams DA; Hofmann I Am J Hematol; 2015 Apr; 90(4):320-6. PubMed ID: 25580823 [TBL] [Abstract][Full Text] [Related]
15. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia. Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214 [TBL] [Abstract][Full Text] [Related]
16. Early Detection of Myelodysplastic Syndrome/Leukemia-associated Mutations Using NGS Is Critical in Treating Aplastic Anemia. Li X; Wu YH; Cai SS; Li WM; You Y; Zhang M Curr Med Sci; 2019 Apr; 39(2):217-221. PubMed ID: 31016513 [TBL] [Abstract][Full Text] [Related]
17. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry. Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721 [TBL] [Abstract][Full Text] [Related]
18. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity. Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco CM; Cassano E; Danova M; Ucci G; Castello A; Coci A Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832 [TBL] [Abstract][Full Text] [Related]
20. Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA). Li X; Xu F; He Q; Wu L; Zhang Z; Chang C Intern Med; 2010; 49(14):1349-55. PubMed ID: 20647647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]